151 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
,” “anticipate,” “estimate,” “expects,” “projects,” “intends,” “plans,” “believes,” “seek,” “could,” “continue,” “likely,” “will,” “strategy” and “goal … providers to better detect, treat, and prevent disease. Our Business Strategy Personalized genetic data, digital, and virtual consumer trends are converging
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
27 Feb 24
Results of Operations and Financial Condition
4:05pm
of the Future strategy and technology investments, including EMR integrations, designed to enhance our ability to serve more patients seamlessly and efficiently … quarter and fiscal year 2024 financial guidance, and statements relating to the company's continuing investment in Labs of the Future strategy
8-K
MYGN
Myriad Genetics, Inc.
27 Feb 24
Results of Operations and Financial Condition
4:05pm
financial guidance, and statements relating to the company's continuing investment in Labs of the Future strategy and technology investments
8-K
EX-99.1
tkjvuhilco
21 Dec 23
Departure of Directors or Certain Officers
8:30am
424B5
j18joe3 phzwv0
13 Nov 23
Prospectus supplement for primary offering
6:02am
424B5
ukhkkh1bobq1snek08hc
8 Nov 23
Prospectus supplement for primary offering
4:05pm
S-3ASR
7wh8q
8 Nov 23
Automatic shelf registration
4:01pm
8-K
EX-10.1
qjkceky3myabc cxu
1 Nov 23
Departure of Directors or Certain Officers
9:00am
8-K
5mrosnd
1 Nov 23
Departure of Directors or Certain Officers
9:00am
8-K
EX-99.1
gw6v7f32co20mo7esgiy
6 Jul 23
Entry into a Material Definitive Agreement
8:24am
8-K
EX-10.1
jj1 2r0shl
6 Jul 23
Entry into a Material Definitive Agreement
8:24am
ARS
ohi wxyzjocjkk6280
12 Apr 23
Annual report to shareholders
4:10pm